While the condition is relatively uncommon, it is clinically important because the localized inflammation can lead to scarring, vision loss, or secondary infection if not treated promptly.

• Typical age range: 20–60 years, with a slight male predominance (≈55%).
• Geographic prevalence: Higher incidence in tropical and subtropical regions where ocular trauma from vegetation or exposure to certain microbes is more frequent.
• Incidence: Exact worldwide rates are not well‑documented, but studies from ophthalmology clinics suggest that zonal keratitis accounts for 5‑10 % of all microbial keratitis cases in endemic areas (J Ophthalmic Inflamm Infect. 2021).

Symptoms

Symptoms may appear suddenly or develop over several days. The pattern often mirrors the location of the inflamed zone.

• Eye pain or discomfort – aching, throbbing, or a gritty sensation.
• Redness – localized to the affected sector; may be accompanied by conjunctival injection.
• Photophobia – increased sensitivity to light, especially when looking toward the affected zone.
• Blurred or reduced vision – when the inflammation encroaches on the visual axis.
• Foreign‑body sensation – feeling that something is in the eye.
• Tearing (epiphora) – excessive tearing as the eye attempts to protect itself.
• Discharge – can be watery, mucoid, or purulent depending on the underlying cause.
• Spot or ulcer – visible opacity or ulceration on slit‑lamp examination.
• Eye swelling (periorbital edema) – uncommon but may occur if inflammation spreads.

Causes and Risk Factors

Infectious Causes

• Bacterial – Pseudomonas aeruginosa, Staphylococcus aureus, and Streptococcus pneumoniae are frequent culprits, especially after contact‑lens wear or corneal trauma.
• Fungal – Fusarium and Aspergillus species are common in agricultural settings.
• Amoebic – Acantamoeba spp. (rare, but severe).
• Viral – Herpes simplex virus (HSV) keratitis can present as a zonal infection, especially in the peripheral cornea.

Non‑infectious Causes

• Autoimmune/Inflammatory – Peripheral ulcerative keratitis associated with rheumatoid arthritis, granulomatosis with polyangiitis, or Stevens‑Johnson syndrome.
• Allergic – Vernal keratoconjunctivitis may lead to localized corneal inflammation.
• Toxic/Chemical – Exposure to acids, alkalis, or ocular drops containing preservatives.
• Trauma – Penetrating or blunt injury introducing organisms or debris into a localized corneal zone.

Risk Factors

• Contact‑lens wear (especially extended‑wear or poor hygiene).
• Outdoor occupations (farming, construction) that increase exposure to plant material and soil.
• Pre‑existing ocular surface disease (dry eye, blepharitis).
• Systemic autoimmune disorders.
• Immunosuppression (diabetes, HIV, systemic steroids).
• Recent eye surgery or laser procedures.

Diagnosis

Accurate diagnosis combines a thorough history, detailed eye examination, and targeted laboratory testing.

Clinical Examination

• Visual acuity testing – establishes baseline vision.
• Slit‑lamp biomicroscopy – essential for locating the zone, assessing ulcer size, depth, and presence of infiltrates.
• Fluorescein staining – highlights epithelial defects; the pattern helps differentiate infectious from non‑infectious causes.
• Seidel test – checks for leaking fluid in cases of suspected perforation.

Laboratory & Imaging Tools

• Corneal scrapings – obtained with a sterile blade for gram stain, potassium hydroxide (KOH) wet mount, and culture (bacterial, fungal, or Acanthamoeba).
• Polymerase chain reaction (PCR) – rapid detection of viral DNA (e.g., HSV) or atypical bacteria.
• In‑vivo confocal microscopy – non‑invasive imaging that can visualize organisms in the cornea.
• Anterior segment optical coherence tomography (AS‑OCT) – measures corneal thickness and ulcer depth.

Because the clinical picture can overlap with other corneal diseases, culture and PCR results are crucial for guiding targeted therapy.

Treatment Options

General Principles

• Prompt initiation of antimicrobial therapy when infection is suspected.
• Address underlying systemic disease (e.g., rheumatologic control for autoimmune zonulitis).
• Protect the cornea with a therapeutic bandage or patch if epithelial defects are large.

Medications

Antibiotics (bacterial)

• Topical fluoroquinolones (e.g., moxifloxacin 0.5 %) – first‑line for most bacterial keratitis.
• For MRSA or resistant organisms: fortified vancomycin (25 mg/mL) plus tobramycin (14 mg/mL).
• Systemic antibiotics (oral ciprofloxacin or IV cephalosporins) may be added for deep or perforating ulcers.

Antifungals (fungal)

• Topical natamycin 5 % (first‑line for filamentous fungi).
• Voriconazole 1 % eye drops – useful for resistant or deep infections.
• Oral itraconazole or fluconazole for severe cases.

Antivirals (viral)

• Topical trifluridine 1 % or ganciclovir 0.15 % for HSV keratitis.
• Oral acyclovir 400 mg five times daily for 7–10 days is often recommended to prevent stromal involvement.

Anti‑inflammatory & Immunomodulatory

• Topical corticosteroids (e.g., prednisolone acetate 1 %) – only after infection is controlled, to reduce stromal inflammation and scarring.
• Non‑steroidal anti‑inflammatory drugs (NSAIDs) can be used for pain, but caution is advised as they may impair healing.
• Systemic immunosuppressants (e.g., methotrexate, mycophenolate) for autoimmune zonal keratitis under rheumatology supervision.

Procedural Interventions

• Debridement – mechanical removal of necrotic tissue to improve drug penetration.
• Therapeutic penetrating keratoplasty – corneal transplant for perforation or non‑healing deep ulcers.
• Amniotic membrane transplantation – promotes epithelial healing and reduces inflammation.
• Collagen cross‑linking (CXL) – emerging option for resistant infectious keratitis to strengthen corneal stroma.

Lifestyle & Supportive Measures

• Lubricating eye drops (preservative‑free) to maintain surface moisture.
• Eye shield or patch at night to prevent accidental rubbing.
• Strict hygiene: hand washing, lens disinfection, and avoiding water exposure while wearing contacts.

Living with Zonulitis (zonal keratitis)

Daily Management Tips

• Medication adherence – set alarms or use a pill tracker; missing doses can allow organisms to proliferate.
• Follow‑up appointments – most clinicians schedule visits every 24‑48 hours initially to monitor healing.
• Protective eyewear – sunglasses with UV protection reduce photophobia and prevent further trauma.
• Contact‑lens hygiene – if you wear lenses, switch to daily disposables during treatment and discard all lenses and cases.
• Nutrition – a diet rich in omega‑3 fatty acids (e.g., fish, flaxseed) may support ocular surface health.
• Environmental control – use a humidifier in dry climates; avoid smoke, chemicals, and dusty environments that can irritate the eye.

Psychosocial Aspects

Vision changes can cause anxiety and affect daily activities. Consider:

• Vision rehabilitation services if scarring leads to permanent visual impairment.
• Support groups for chronic eye disease.
• Consulting a mental‑health professional if anxiety or depression develops.

Prevention

• Hand and eye hygiene – wash hands before touching eyes; avoid rubbing.
• Contact‑lens safety – follow the manufacturer’s replacement schedule, use proper disinfecting solutions, and never sleep in lenses unless approved.
• Protective eyewear – wear goggles when gardening, DIY projects, or working with chemicals.
• Prompt treatment of ocular surface disease – dry eye, blepharitis, or allergic conjunctivitis should be managed early.
• Systemic disease control – keep rheumatoid arthritis, diabetes, and other conditions well‑controlled with the help of your physician.
• Vaccinations – the herpes zoster vaccine (Shingrix) reduces the risk of HSV‑related eye disease in adults over 50.

Complications

If zonulitis is not treated promptly or adequately, several serious complications can arise:

• Corneal scarring – may cause permanent visual acuity loss.
• Corneal perforation – a surgical emergency requiring graft or glue.
• Endophthalmitis – infection spreading to the interior of the eye.
• Secondary glaucoma – elevated intra‑ocular pressure from inflammation.
• Symblepharon – adhesion between the eyelid and globe in severe inflammatory disease.
• Loss of eye (enucleation) – rare, but can occur when infection is uncontrolled.

When to Seek Emergency Care

Sources: Mayo Clinic. “Keratitis.” 2023; CDC. “Trachoma and Other Ocular Infections.” 2022; National Eye Institute. “Eye Health Statistics.” 2021; WHO. “Global Burden of Infectious Eye Diseases.” 2020; Cleveland Clinic. “Corneal Ulcer Treatment.” 2023; J Ophthalmic Inflamm Infect. “Epidemiology of Zonal Keratitis in Tropical Regions.” 2021.